UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 486

Sortiert nach

A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers

Nature communications, 2018-08, Vol.9 (1), p.3196-15, Article 3196

2018

Volltextzugriff (PDF)

Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error

British journal of cancer, 2014-09, Vol.111 (6), p.1201-1212

2014

Volltextzugriff (PDF)

Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma

Oncogene, 2006-11, Vol.25 (52), p.6959-6967

2006

Volltextzugriff (PDF)

Prognostic Significance of p16 Protein Levels in Oropharyngeal Squamous Cell Cancer

Clinical cancer research, 2004-09, Vol.10 (17), p.5684-5691

2004

Volltextzugriff (PDF)

HSP90 as a marker of progression in melanoma

Annals of oncology, 2008-03, Vol.19 (3), p.590-594

2008

Volltextzugriff (PDF)

Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR Her2 inhibitor in non-small-cell lung cancer cells

British journal of cancer, 2009-03, Vol.100 (6), p.941-949

2009

Volltextzugriff (PDF)

Immunological differences between primary and metastatic breast cancer

Annals of oncology, 2018-11, Vol.29 (11), p.2232-2239

2018

Volltextzugriff (PDF)

Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer

Annals of oncology, 2010-03, Vol.21 (3), p.466-473

2010

Volltextzugriff (PDF)

Validation of Tissue Microarray Technology in Breast Carcinoma

Laboratory investigation, 2000-12, Vol.80 (12), p.1943-1949

2000

Volltextzugriff (PDF)

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

Annals of oncology, 2015-02, Vol.26 (2), p.259-271

2015

Volltextzugriff (PDF)

EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial

British journal of cancer, 2014-09, Vol.111 (6), p.1065-1071

2014

Volltextzugriff (PDF)

Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma

Cancer, 1999-12, Vol.86 (11), p.2259-2265

1999

Volltextzugriff (PDF)

Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancer

Annals of oncology, 2012-08, Vol.23 (8), p.2059-2064

2012

Volltextzugriff (PDF)

Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial

Annals of oncology, 2017-01, Vol.28 (1), p.128-135

2017

Volltextzugriff (PDF)

Frequent mutation and nuclear localization of β-catenin in anaplastic thyroid carcinoma

Cancer research (Chicago, Ill.), 1999-04, Vol.59 (8), p.1811-1815

1999

Volltextzugriff (PDF)

B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma

Annals of oncology, 2024-04, Vol.35 (4), p.340-350

2024

Volltextzugriff (PDF)

Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation

Oncogene, 2014-03, Vol.33 (11), p.1438-1447

2014

Volltextzugriff (PDF)

Frequent Nuclear/Cytoplasmic Localization of β-Catenin without Exon 3 Mutations in Malignant Melanoma

The American journal of pathology, 1999-02, Vol.154 (2), p.325-329

1999

Volltextzugriff (PDF)

Expression of c‐met is a strong independent prognostic factor in breast carcinoma

Cancer, 1998-04, Vol.82 (8), p.1513-1520

1998

Volltextzugriff (PDF)

β-Catenin Functions Mainly as an Adhesion Molecule in Patients with Squamous Cell Cancer of the Head and Neck

Clinical cancer research, 2005-04, Vol.11 (7), p.2471-2477

2005

Volltextzugriff (PDF)

Quantitative assessment of miR34a as an independent prognostic marker in breast cancer

British journal of cancer, 2015-01, Vol.112 (1), p.61-68

2015

Volltextzugriff (PDF)

Automated subcellular localization and quantification of protein expression in tissue microarrays

Nature medicine, 2002-11, Vol.8 (11), p.1323-1328

2002

Volltextzugriff (PDF)

Tissue microarray: a new technology for amplification of tissue resources

The cancer journal (Sudbury, Mass.), 2001-01, Vol.7 (1), p.24

2001

Volltextzugriff (PDF)

Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial

Annals of oncology, 2019-06, Vol.30 (6), p.1018-1018

2019

Volltextzugriff (PDF)

Automated quantitative analysis of DCC tumor suppressor protein in ovarian cancer tissue microarray shows association with β-catenin levels and outcome in patients with epithelial ovarian cancer

Annals of oncology, 2006-12, Vol.17 (12), p.1797-1802

2006

Volltextzugriff (PDF)

1 – 25 von 486

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(468)
Mit Volltextzugriff
(431)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers

Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error

Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma

Prognostic Significance of p16 Protein Levels in Oropharyngeal Squamous Cell Cancer

HSP90 as a marker of progression in melanoma

Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR Her2 inhibitor in non-small-cell lung cancer cells

Immunological differences between primary and metastatic breast cancer

Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer

Validation of Tissue Microarray Technology in Breast Carcinoma

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial

Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma

Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancer

Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial

Frequent mutation and nuclear localization of β-catenin in anaplastic thyroid carcinoma

B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma

Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation

Frequent Nuclear/Cytoplasmic Localization of β-Catenin without Exon 3 Mutations in Malignant Melanoma

Expression of c‐met is a strong independent prognostic factor in breast carcinoma

β-Catenin Functions Mainly as an Adhesion Molecule in Patients with Squamous Cell Cancer of the Head and Neck

Quantitative assessment of miR34a as an independent prognostic marker in breast cancer

Automated subcellular localization and quantification of protein expression in tissue microarrays

Tissue microarray: a new technology for amplification of tissue resources

Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial

Automated quantitative analysis of DCC tumor suppressor protein in ovarian cancer tissue microarray shows association with β-catenin levels and outcome in patients with epithelial ovarian cancer

Suchergebnisse filtern